CMS finalized a 2.48% increase in Medicare Advantage payment rates for 2027 on April 6 2026, a change that will raise the average reimbursement for plans nationwide by roughly $13 billion. The adjustment is the largest uplift since the agency’s 2023 Advance Notice, which proposed a modest 0.09% increase for the same year. The final rate is therefore a significant revision from the earlier proposal and represents a clear policy shift that benefits insurers operating in the Medicare Advantage market.
UnitedHealth Group, the largest Medicare Advantage insurer, is positioned to capture a substantial portion of the additional payments. The 2.48% increase translates into higher per‑member per‑month (PMPM) rates for UnitedHealth’s plans, improving the company’s margin outlook by offsetting rising medical cost trends. The adjustment also reduces the uncertainty that had weighed on UnitedHealth’s earnings guidance, allowing management to focus on its margin recovery strategy.
In its most recent earnings, UnitedHealth reported Q4 2025 adjusted earnings per share of $2.11, beating estimates of $2.09, and a full‑year 2025 adjusted EPS of $16.35. Revenue for 2025 reached $447.6 billion, a 12% year‑over‑year increase, while the net margin stood at 2.7% and the adjusted medical care ratio (MCR) was 88.9%. In January 2026, the company guided for 2026 revenue of more than $439 billion and adjusted earnings of more than $17.75 per share, reflecting a modest revenue contraction forecast of at least 2%.
Management highlighted the challenges and the company’s response. CEO Stephen Hemsley said, "We confronted challenges directly and finished 2025 as a much stronger company, giving us the momentum to better serve those who count on us and continue to improve our core performance." UnitedHealthcare CEO Tim Noel added, "Our 2026 approach favored margin recovery over any specific membership targets." CFO Wayne DeVeydt noted, "2025 was a year of challenges on multiple fronts."
The rate increase comes at a time when UnitedHealth faces several headwinds. Historically high medical spending in 2025, with a Medicare medical cost trend of 7.5% and an expected 10% rise in 2026, has compressed margins. Membership contraction is projected at 1.3 million to 1.4 million in Medicare Advantage for 2026, and total membership is expected to decline by more than 3 million due to repricing efforts. Regulatory changes, including prior Medicare funding reductions and the Inflation Reduction Act, have also impacted earnings. CMS will continue to use the 2024 Medicare Advantage risk‑adjustment model for 2027, providing plans more time to adjust. The 2.48% rate increase therefore serves as a tailwind that helps UnitedHealth offset these cost pressures and supports its margin recovery strategy.
Overall, the finalized Medicare Advantage rate increase provides UnitedHealth Group with a clearer revenue base for its largest enrollment segment, strengthens its competitive position, and offers a more favorable outlook for margin recovery in the face of rising medical costs and membership headwinds.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.